ABIO logo

ARCA Biopharma (ABIO) Cash From Financing

Annual CFF

$0.00
$0.000.00%

December 31, 2023

Summary

Performance

1-Year Change

0%

3-Year Change

-100%

5-Year Change

-100%

15-Year Change

-100%

ABIO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$121.69 M
ABIO annual cash flow from financing activities is currently -100.00% below its historical high of $121.69 million

3-Year Low

$0.00
ABIO annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ABIO next annual earnings announcement has not yet been scheduled

OtherABIOcash flowmetrics:

Annual CFI

$0.00
ABIO annual cash flow from investing activities is $0.00

Annual CFO

-$5.01 M
ABIO annual cash flow from operations is -$5.01 million

Annual FCF

-$5.01 M
ABIO annual free cash flow is -$5.01 million

Annual CAPEX

-
ABIO annual capital expenditures value is unknown

Quarterly CFF

$14.00 K
+$14.00 K+100.00%

June 30, 2024

Summary

Performance

3-Month Change

+100%

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

+100%

ABIO Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$112.32 M
ABIO quarterly cash flow from financing activities is currently -99.99% below its historical high of $112.32 million

3-Year Low

$0.00
ABIO quarterly cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIOcash flowmetrics:

Quarterly CFI

$0.00
ABIO quarterly cash flow from investing activities is $0.00

Quarterly CFO

-$2.63 M
ABIO quarterly cash flow from operations is -$2.63 million

Quarterly FCF

-$2.63 M
ABIO quarterly free cash flow is -$2.63 million

Quarterly CAPEX

-
ABIO quarterly capital expenditures value is unknown

TTM CFF

$14.00 K
+$14.00 K+100.00%

June 30, 2024

Summary

Performance

3-Month Change

+100%

1-Year Change

+100%

3-Year Change

-99.94%

5-Year Change

-99.94%

ABIO TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$125.03 M
ABIO TTM cash flow from financing activities is currently -99.99% below its historical high of $125.03 million

3-Year Low

$0.00
ABIO TTM cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIOcash flowmetrics:

TTM CFI

$0.00
ABIO TTM cash flow from investing activities is $0.00

TTM CFO

-$6.89 M
ABIO TTM cash flow from operations is -$6.89 million

TTM FCF

-$6.89 M
ABIO TTM free cash flow is -$6.89 million

TTM CAPEX

-
ABIO TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ABIO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year0.0%+100.0%+100.0%
3 y3 years-100.0%+100.0%-99.9%
5 y5 years-100.0%+100.0%-99.9%

ABIO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at lowat high-100.0%-99.9%-100.0%
5 y5-year-100.0%at low-100.0%-971.4%-100.0%-100.0%
alltimeall time-100.0%<-9999.0%-100.0%<-9999.0%-100.0%<-9999.0%

ARCA Biopharma Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2024
-
$14.00 K(>+9900.0%)
$14.00 K(>+9900.0%)
Mar 2024
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2023
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2023
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2022
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2022
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2022
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2022
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2021
$23.09 M(-52.3%)
$0.00(0.0%)
$23.09 M(-4.1%)
Sep 2021
-
$0.00(0.0%)
$24.08 M(-63.6%)
Jun 2021
-
$0.00(-100.0%)
$66.13 M(-7.6%)
Mar 2021
-
$23.09 M(+2246.8%)
$71.55 M(+47.7%)
Dec 2020
$48.45 M(+638.6%)
$984.00 K(-97.7%)
$48.45 M(+2.3%)
Sep 2020
-
$42.06 M(+677.1%)
$47.35 M(+708.2%)
Jun 2020
-
$5.41 M(>+9900.0%)
$5.86 M(+62.9%)
Mar 2020
-
$0.00(-100.0%)
$3.60 M(-45.2%)
Dec 2019
$6.56 M(+111.3%)
-$122.00 K(-121.5%)
$6.56 M(-0.3%)
Sep 2019
-
$568.00 K(-82.0%)
$6.58 M(+9.5%)
Jun 2019
-
$3.15 M(+6.3%)
$6.01 M(+126.6%)
Mar 2019
-
$2.96 M(-2922.9%)
$2.65 M(-14.6%)
Dec 2018
$3.10 M(-46.9%)
-$105.00 K(<-9900.0%)
$3.10 M(-3.5%)
Sep 2018
-
$0.00(-100.0%)
$3.22 M(-55.1%)
Jun 2018
-
-$207.00 K(-106.1%)
$7.16 M(-21.8%)
Mar 2018
-
$3.42 M(>+9900.0%)
$9.16 M(+56.6%)
Dec 2017
$5.85 M(-82.8%)
$7000.00(-99.8%)
$5.85 M(+0.1%)
Sep 2017
-
$3.95 M(+120.7%)
$5.84 M(+208.5%)
Jun 2017
-
$1.79 M(+1602.9%)
$1.89 M(+1702.9%)
Mar 2017
-
$105.00 K(>+9900.0%)
$105.00 K(-281.0%)
Sep 2016
-
$0.00(0.0%)
-$58.00 K(-77.5%)
Jun 2016
-
$0.00(0.0%)
-$258.00 K(-100.8%)
Mar 2016
-
$0.00(-100.0%)
$34.05 M(+0.2%)
Dec 2015
$33.99 M(+323.7%)
-$58.00 K(-71.0%)
$33.99 M(-0.2%)
Sep 2015
-
-$200.00 K(-100.6%)
$34.05 M(-0.4%)
Jun 2015
-
$34.31 M(<-9900.0%)
$34.20 M(<-9900.0%)
Mar 2015
-
-$55.00 K(+2650.0%)
-$165.00 K(-102.1%)
Dec 2014
$8.02 M(-58.1%)
-$2000.00(-96.1%)
$8.02 M(-0.0%)
Sep 2014
-
-$51.00 K(-10.5%)
$8.03 M(+0.0%)
Jun 2014
-
-$57.00 K(-100.7%)
$8.02 M(-69.0%)
Mar 2014
-
$8.13 M(>+9900.0%)
$25.90 M(+35.2%)
Dec 2013
$19.16 M(+1715.7%)
$0.00(-100.0%)
$19.16 M(-2.6%)
Sep 2013
-
-$55.00 K(-100.3%)
$19.66 M(-3.6%)
Jun 2013
-
$17.82 M(+1182.1%)
$20.39 M(+714.1%)
Mar 2013
-
$1.39 M(+173.6%)
$2.50 M(+137.4%)
Dec 2012
$1.05 M(-72.7%)
$508.00 K(-24.6%)
$1.05 M(-46.5%)
Sep 2012
-
$674.00 K(-1106.0%)
$1.97 M(+56.7%)
Jun 2012
-
-$67.00 K(+11.7%)
$1.26 M(-67.0%)
Mar 2012
-
-$60.00 K(-104.2%)
$3.81 M(-1.5%)
Dec 2011
$3.87 M(-47.1%)
$1.43 M(-3665.0%)
$3.87 M(+58.3%)
Sep 2011
-
-$40.00 K(-101.6%)
$2.44 M(-1.6%)
Jun 2011
-
$2.48 M(>+9900.0%)
$2.49 M(-66.0%)
Mar 2011
-
$0.00(0.0%)
$7.32 M(0.0%)
Dec 2010
$7.32 M
$0.00(-100.0%)
$7.32 M(-0.3%)
DateAnnualQuarterlyTTM
Sep 2010
-
$1000.00(-100.0%)
$7.34 M(+67.8%)
Jun 2010
-
$7.32 M(>+9900.0%)
$4.38 M(-212.6%)
Dec 2009
-$3.89 M(-130.3%)
$19.00 K(-100.6%)
-$3.89 M(-144.4%)
Sep 2009
-
-$2.96 M(+567.6%)
$8.75 M(-26.2%)
Jun 2009
-
-$444.00 K(-10.7%)
$11.86 M(-3.0%)
Mar 2009
-
-$497.00 K(-103.9%)
$12.22 M(-4.5%)
Dec 2008
$12.80 M(-476.5%)
$12.66 M(+8813.4%)
$12.80 M(<-9900.0%)
Sep 2008
-
$142.00 K(-282.1%)
-$44.00 K(-97.1%)
Jun 2008
-
-$78.00 K(-194.0%)
-$1.54 M(-36.0%)
Mar 2008
-
$83.00 K(-143.5%)
-$2.40 M(-29.4%)
Dec 2007
-$3.40 M(-102.8%)
-$191.00 K(-85.9%)
-$3.40 M(-141.3%)
Sep 2007
-
-$1.35 M(+43.2%)
$8.24 M(-28.1%)
Jun 2007
-
-$943.00 K(+2.8%)
$11.45 M(+35.4%)
Mar 2007
-
-$917.00 K(-108.0%)
$8.46 M(-93.0%)
Dec 2006
$121.69 M(+49.9%)
$11.45 M(+513.1%)
$121.69 M(-1.6%)
Sep 2006
-
$1.87 M(-147.4%)
$123.61 M(+1.3%)
Jun 2006
-
-$3.94 M(-103.5%)
$122.02 M(-2.4%)
Mar 2006
-
$112.32 M(+740.2%)
$125.03 M(+54.0%)
Dec 2005
$81.16 M(+20.5%)
$13.37 M(+4850.7%)
$81.16 M(+21.4%)
Sep 2005
-
$270.00 K(-129.1%)
$66.85 M(-0.4%)
Jun 2005
-
-$927.00 K(-101.4%)
$67.11 M(+0.2%)
Mar 2005
-
$68.45 M(-7359.1%)
$66.98 M(-0.6%)
Dec 2004
$67.36 M(+144.1%)
-$943.00 K(-280.3%)
$67.36 M(-29.7%)
Sep 2004
-
$523.00 K(-149.5%)
$95.79 M(-0.0%)
Jun 2004
-
-$1.06 M(-101.5%)
$95.80 M(-0.1%)
Mar 2004
-
$68.83 M(+150.4%)
$95.92 M(+247.7%)
Dec 2003
$27.59 M(+21.0%)
$27.48 M(+5037.4%)
$27.59 M(+388.8%)
Sep 2003
-
$535.00 K(-157.1%)
$5.64 M(+12.9%)
Jun 2003
-
-$937.00 K(-285.2%)
$5.00 M(-74.6%)
Mar 2003
-
$506.00 K(-90.9%)
$19.69 M(-13.7%)
Dec 2002
$22.80 M(-48.5%)
$5.54 M(-5182.6%)
$22.80 M(+7.3%)
Sep 2002
-
-$109.00 K(-100.8%)
$21.26 M(-49.8%)
Jun 2002
-
$13.75 M(+279.5%)
$42.35 M(+50.0%)
Mar 2002
-
$3.62 M(-9.4%)
$28.23 M(-36.3%)
Dec 2001
$44.29 M(+3368.4%)
$4.00 M(-80.9%)
$44.29 M(+11.0%)
Sep 2001
-
$20.98 M(-5801.1%)
$39.89 M(+111.3%)
Jun 2001
-
-$368.00 K(-101.9%)
$18.88 M(-9.9%)
Mar 2001
-
$19.68 M(-4996.3%)
$20.97 M(+1541.8%)
Dec 2000
$1.28 M(-20.2%)
-$402.00 K(+1196.8%)
$1.28 M(-35.5%)
Sep 2000
-
-$31.00 K(-101.8%)
$1.98 M(-29.6%)
Jun 2000
-
$1.72 M(<-9900.0%)
$2.81 M(+40.9%)
Mar 2000
-
-$6000.00(-102.0%)
$1.99 M(+24.6%)
Dec 1999
$1.60 M(-71.4%)
$300.00 K(-62.5%)
$1.60 M(-74.2%)
Sep 1999
-
$800.00 K(-11.1%)
$6.20 M(+12.7%)
Jun 1999
-
$900.00 K(-325.0%)
$5.50 M(+5.8%)
Mar 1999
-
-$400.00 K(-108.2%)
$5.20 M(-7.1%)
Dec 1998
$5.60 M(-90.9%)
$4.90 M(+4800.0%)
$5.60 M(+600.0%)
Sep 1998
-
$100.00 K(-83.3%)
$800.00 K(-98.5%)
Jun 1998
-
$600.00 K(>+9900.0%)
$52.10 M(-15.4%)
Mar 1998
-
$0.00(-100.0%)
$61.60 M(0.0%)
Dec 1997
$61.60 M(+450.0%)
$100.00 K(-99.8%)
$61.60 M(+0.2%)
Sep 1997
-
$51.40 M(+408.9%)
$61.50 M(+508.9%)
Jun 1997
-
$10.10 M(>+9900.0%)
$10.10 M(>+9900.0%)
Mar 1997
-
$0.00
$0.00
Dec 1996
$11.20 M
-
-

FAQ

  • What is ARCA biopharma annual cash flow from financing activities?
  • What is the all time high annual CFF for ARCA biopharma?
  • What is ARCA biopharma annual CFF year-on-year change?
  • What is ARCA biopharma quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for ARCA biopharma?
  • What is ARCA biopharma quarterly CFF year-on-year change?
  • What is ARCA biopharma TTM cash flow from financing activities?
  • What is the all time high TTM CFF for ARCA biopharma?
  • What is ARCA biopharma TTM CFF year-on-year change?

What is ARCA biopharma annual cash flow from financing activities?

The current annual CFF of ABIO is $0.00

What is the all time high annual CFF for ARCA biopharma?

ARCA biopharma all-time high annual cash flow from financing activities is $121.69 M

What is ARCA biopharma annual CFF year-on-year change?

Over the past year, ABIO annual cash flow from financing activities has changed by $0.00 (0.00%)

What is ARCA biopharma quarterly cash flow from financing activities?

The current quarterly CFF of ABIO is $14.00 K

What is the all time high quarterly CFF for ARCA biopharma?

ARCA biopharma all-time high quarterly cash flow from financing activities is $112.32 M

What is ARCA biopharma quarterly CFF year-on-year change?

Over the past year, ABIO quarterly cash flow from financing activities has changed by +$14.00 K (+100.00%)

What is ARCA biopharma TTM cash flow from financing activities?

The current TTM CFF of ABIO is $14.00 K

What is the all time high TTM CFF for ARCA biopharma?

ARCA biopharma all-time high TTM cash flow from financing activities is $125.03 M

What is ARCA biopharma TTM CFF year-on-year change?

Over the past year, ABIO TTM cash flow from financing activities has changed by +$14.00 K (+100.00%)